Evidence map›Paper›PMID 31045806›Full record

ArticleMedicine2019

A case report of hepatitis B related optic neuritis treated with plasma exchange.

Da Teng, Shaoying Tan, Mo Yang, Junqing Wang, Jie Zhao, Quangang Xu, Shihui Wei

Open access · goldAbstract readCase Reports
In one paragraph

Article in Medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Da TengMedical School of Nankai University, Tianjin.
Shaoying TanShenzhen University General Hospital and Shenzhen University Clinical Medical Academy, Shenzhen.
Mo YangOphthalmology Department, Chinese PLA General Hospital, Beijing.
Junqing WangOphthalmology Department, Chinese PLA General Hospital, Beijing.
Jie ZhaoBeijing MEM Eye Hospital, Beijing, China.
Quangang XuOphthalmology Department, Chinese PLA General Hospital, Beijing.
Shihui WeiOphthalmology Department, Chinese PLA General Hospital, Beijing.
Chinese PLA General Hospital · CNNankai University · CNSouthern Medical University Shenzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere are few studies focusing on Binocular hepatitis B related optic neuritis (HB-ON) and associated therapies are still limited. We present a case of HB-ON which has been cured with therapeutic plasma exchange (TPE). PATIENT CONCERNS: The patient was diagnosed as acute hepatitis B in hepatology and got a rapid loss of binocular visual acuity (2/100 in the right eye and no light perception in the left eye) after the onset. DIAGNOSIS: Hepatitis B related optic neuritis.

interventionsMethylprednisolone and therapeutic plasma exchange. OUTCOMES: The treatment of high dose methylprednisolone was not curative. After 5 TPE sessions, the patient's best corrected visual acuity (BCVA) returned to 20/20 in the right eye and finger counting (FC)/40 cm in the left eye. One month later, the visual acuity increased to 5/100 in the left eye.

conclusionThis is the first case in which we used TPE to cure HB-ON. Also, it can demonstrate the relationship between HB-ON and immunopathogenesis. The case may provide an effective method for the treatment of hormone invalid and disabled ON in clinical practice.

Indexed as

Acute DiseaseAdultAnti-Inflammatory AgentsHepatitis BHumansMaleMethylprednisoloneOptic NeuritisPlasmapheresisVisual AcuityAnti-Inflammatory AgentsMethylprednisolone

Identifiers

PMID31045806
PMCPMC6504246
OpenAlexW2943699012

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.